Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 126 | 2025 | 1284 | 22.640 |
Why?
|
Aminophenols | 27 | 2024 | 93 | 6.390 |
Why?
|
Quinolones | 24 | 2024 | 387 | 5.410 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 27 | 2024 | 452 | 4.470 |
Why?
|
Benzodioxoles | 16 | 2024 | 80 | 3.770 |
Why?
|
Deoxyribonuclease I | 7 | 2024 | 228 | 1.820 |
Why?
|
Aminopyridines | 6 | 2021 | 576 | 1.760 |
Why?
|
Self Care | 8 | 2017 | 800 | 1.700 |
Why?
|
Achilles Tendon | 4 | 2024 | 181 | 1.300 |
Why?
|
Needs Assessment | 9 | 2021 | 1140 | 1.290 |
Why?
|
Cost of Illness | 7 | 2021 | 1949 | 1.070 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2024 | 704 | 1.060 |
Why?
|
Telemedicine | 7 | 2024 | 3108 | 1.060 |
Why?
|
Registries | 14 | 2024 | 8346 | 1.040 |
Why?
|
Forced Expiratory Volume | 13 | 2024 | 1828 | 1.020 |
Why?
|
Parents | 8 | 2019 | 3591 | 0.980 |
Why?
|
Pulmonary Medicine | 3 | 2024 | 223 | 0.950 |
Why?
|
Indoles | 9 | 2024 | 1833 | 0.920 |
Why?
|
Respiratory Function Tests | 12 | 2021 | 1692 | 0.920 |
Why?
|
Thioglycolates | 1 | 2024 | 37 | 0.910 |
Why?
|
Polycyclic Compounds | 1 | 2024 | 28 | 0.900 |
Why?
|
Heel | 1 | 2024 | 38 | 0.900 |
Why?
|
Medication Therapy Management | 2 | 2018 | 131 | 0.850 |
Why?
|
Diterpenes | 1 | 2024 | 166 | 0.840 |
Why?
|
Adolescent | 83 | 2024 | 88811 | 0.830 |
Why?
|
Models, Organizational | 4 | 2021 | 548 | 0.820 |
Why?
|
Continuity of Patient Care | 4 | 2021 | 1075 | 0.800 |
Why?
|
Child | 68 | 2025 | 80568 | 0.790 |
Why?
|
Health Services Accessibility | 8 | 2021 | 5509 | 0.780 |
Why?
|
Chronic Disease | 15 | 2024 | 9351 | 0.780 |
Why?
|
Patient Compliance | 5 | 2017 | 2693 | 0.770 |
Why?
|
Spirometry | 2 | 2022 | 929 | 0.760 |
Why?
|
Communication Barriers | 2 | 2021 | 418 | 0.750 |
Why?
|
Locomotion | 2 | 2024 | 384 | 0.750 |
Why?
|
Lung | 17 | 2022 | 10046 | 0.730 |
Why?
|
Young Adult | 66 | 2024 | 59857 | 0.730 |
Why?
|
Deductibles and Coinsurance | 1 | 2023 | 315 | 0.700 |
Why?
|
Drug Combinations | 8 | 2024 | 2075 | 0.700 |
Why?
|
Insurance Claim Review | 3 | 2018 | 744 | 0.660 |
Why?
|
Walking | 8 | 2024 | 1198 | 0.660 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 560 | 0.650 |
Why?
|
Reproductive Health Services | 4 | 2023 | 90 | 0.640 |
Why?
|
Quality of Life | 17 | 2024 | 13463 | 0.640 |
Why?
|
Equipment and Supplies | 1 | 2021 | 273 | 0.630 |
Why?
|
Humans | 167 | 2025 | 765926 | 0.630 |
Why?
|
Adult | 87 | 2025 | 223088 | 0.620 |
Why?
|
Sex Education | 1 | 2019 | 92 | 0.610 |
Why?
|
Running | 1 | 2023 | 488 | 0.600 |
Why?
|
Adaptation, Psychological | 4 | 2019 | 2662 | 0.580 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 18 | 0.580 |
Why?
|
Pseudomonas Infections | 5 | 2014 | 622 | 0.570 |
Why?
|
Women | 1 | 2018 | 225 | 0.540 |
Why?
|
Asthma | 9 | 2017 | 6268 | 0.510 |
Why?
|
Health Benefit Plans, Employee | 1 | 2018 | 332 | 0.510 |
Why?
|
Disease Progression | 11 | 2022 | 13614 | 0.510 |
Why?
|
Child Health Services | 1 | 2021 | 645 | 0.490 |
Why?
|
Sweat | 4 | 2021 | 57 | 0.490 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 239 | 0.490 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 937 | 0.490 |
Why?
|
Home Care Services | 1 | 2021 | 658 | 0.480 |
Why?
|
Lung Diseases | 3 | 2024 | 1939 | 0.480 |
Why?
|
Tobramycin | 2 | 2012 | 65 | 0.470 |
Why?
|
Male | 101 | 2025 | 363815 | 0.470 |
Why?
|
Homozygote | 5 | 2022 | 1774 | 0.470 |
Why?
|
Eligibility Determination | 1 | 2018 | 422 | 0.470 |
Why?
|
Ethics, Medical | 1 | 2019 | 785 | 0.460 |
Why?
|
Female | 102 | 2025 | 396141 | 0.450 |
Why?
|
Risk Adjustment | 1 | 2018 | 596 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1793 | 0.450 |
Why?
|
Health Status | 6 | 2021 | 4085 | 0.440 |
Why?
|
Treatment Refusal | 1 | 2017 | 433 | 0.430 |
Why?
|
Patient Participation | 2 | 2021 | 1447 | 0.430 |
Why?
|
Health Personnel | 4 | 2023 | 3385 | 0.420 |
Why?
|
Social Perception | 1 | 2017 | 435 | 0.420 |
Why?
|
Cost Savings | 1 | 2018 | 900 | 0.410 |
Why?
|
Quality Improvement | 5 | 2021 | 3847 | 0.410 |
Why?
|
Physician's Role | 1 | 2019 | 925 | 0.410 |
Why?
|
Pseudomonas aeruginosa | 5 | 2019 | 1276 | 0.410 |
Why?
|
Quality of Health Care | 5 | 2021 | 4305 | 0.410 |
Why?
|
Cough | 5 | 2021 | 598 | 0.400 |
Why?
|
Attitude of Health Personnel | 3 | 2023 | 3928 | 0.400 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2024 | 4055 | 0.390 |
Why?
|
Pneumonia | 1 | 2024 | 2158 | 0.390 |
Why?
|
Health Services | 3 | 2016 | 756 | 0.390 |
Why?
|
Health Care Surveys | 2 | 2017 | 2426 | 0.380 |
Why?
|
Ankle Joint | 3 | 2024 | 450 | 0.380 |
Why?
|
Teaching | 1 | 2019 | 1170 | 0.370 |
Why?
|
Self Concept | 1 | 2017 | 1039 | 0.360 |
Why?
|
Pyrazoles | 4 | 2024 | 2031 | 0.360 |
Why?
|
Muscle, Skeletal | 6 | 2024 | 4959 | 0.350 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1662 | 0.350 |
Why?
|
Ambulatory Care | 2 | 2021 | 2778 | 0.350 |
Why?
|
United States | 31 | 2024 | 72909 | 0.350 |
Why?
|
Resilience, Psychological | 1 | 2018 | 808 | 0.340 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15878 | 0.340 |
Why?
|
Recombinant Proteins | 5 | 2024 | 6491 | 0.340 |
Why?
|
Anti-Asthmatic Agents | 2 | 2017 | 572 | 0.340 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1392 | 0.330 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7473 | 0.330 |
Why?
|
Sexual Behavior | 7 | 2022 | 2192 | 0.310 |
Why?
|
Qualitative Research | 4 | 2025 | 3136 | 0.300 |
Why?
|
Women's Health | 1 | 2018 | 2081 | 0.300 |
Why?
|
Caregivers | 5 | 2024 | 2304 | 0.300 |
Why?
|
Drug Costs | 2 | 2013 | 1194 | 0.280 |
Why?
|
Child, Preschool | 26 | 2025 | 42510 | 0.280 |
Why?
|
Patient Advocacy | 1 | 2009 | 361 | 0.280 |
Why?
|
Sinusitis | 3 | 2021 | 995 | 0.280 |
Why?
|
Advance Directives | 1 | 2008 | 249 | 0.270 |
Why?
|
Health Expenditures | 2 | 2018 | 2388 | 0.270 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2021 | 82 | 0.260 |
Why?
|
Mutation | 14 | 2023 | 30192 | 0.260 |
Why?
|
Time | 3 | 2021 | 549 | 0.260 |
Why?
|
Gait | 4 | 2024 | 819 | 0.260 |
Why?
|
Prescription Drugs | 1 | 2013 | 634 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 1881 | 0.250 |
Why?
|
Pyridines | 4 | 2024 | 2885 | 0.250 |
Why?
|
Administration, Inhalation | 4 | 2017 | 1154 | 0.240 |
Why?
|
Hypoglycemia | 2 | 2024 | 896 | 0.240 |
Why?
|
Longitudinal Studies | 14 | 2021 | 14745 | 0.240 |
Why?
|
Pneumonia, Bacterial | 1 | 2008 | 319 | 0.240 |
Why?
|
Counseling | 2 | 2017 | 1551 | 0.230 |
Why?
|
Hospitalization | 6 | 2019 | 10810 | 0.230 |
Why?
|
Torque | 1 | 2024 | 132 | 0.230 |
Why?
|
Health Services Needs and Demand | 4 | 2021 | 1404 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2024 | 1389 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18382 | 0.230 |
Why?
|
Muscle Spindles | 1 | 2023 | 15 | 0.220 |
Why?
|
Pediatrics | 8 | 2024 | 3609 | 0.220 |
Why?
|
Motivation | 1 | 2014 | 2018 | 0.220 |
Why?
|
Employment | 1 | 2010 | 1107 | 0.220 |
Why?
|
Men's Health | 2 | 2022 | 75 | 0.220 |
Why?
|
Perception | 1 | 2010 | 1204 | 0.220 |
Why?
|
Costs and Cost Analysis | 3 | 2021 | 1666 | 0.220 |
Why?
|
Glucocorticoids | 1 | 2013 | 2155 | 0.220 |
Why?
|
Tablets | 1 | 2024 | 149 | 0.210 |
Why?
|
Shoes | 1 | 2024 | 90 | 0.210 |
Why?
|
Postural Balance | 2 | 2024 | 637 | 0.210 |
Why?
|
Steroids | 1 | 2008 | 934 | 0.200 |
Why?
|
Fatigue | 2 | 2021 | 1553 | 0.200 |
Why?
|
Tendons | 2 | 2023 | 555 | 0.200 |
Why?
|
Rhinitis | 2 | 2021 | 752 | 0.200 |
Why?
|
Feedback, Physiological | 1 | 2024 | 480 | 0.200 |
Why?
|
Radius | 2 | 2016 | 440 | 0.200 |
Why?
|
Education, Medical | 1 | 2014 | 1744 | 0.190 |
Why?
|
Interviews as Topic | 4 | 2025 | 2740 | 0.190 |
Why?
|
Pyrrolidines | 4 | 2024 | 337 | 0.190 |
Why?
|
Swimming | 1 | 2023 | 212 | 0.190 |
Why?
|
Gait Disorders, Neurologic | 1 | 2024 | 245 | 0.190 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2331 | 0.190 |
Why?
|
Self Report | 4 | 2024 | 3768 | 0.190 |
Why?
|
Muscles | 2 | 2023 | 1577 | 0.190 |
Why?
|
Comparative Effectiveness Research | 2 | 2018 | 713 | 0.190 |
Why?
|
Health Policy | 1 | 2014 | 2699 | 0.190 |
Why?
|
Respiratory Tract Infections | 3 | 2021 | 1008 | 0.180 |
Why?
|
Gastrostomy | 1 | 2024 | 325 | 0.180 |
Why?
|
Advance Care Planning | 1 | 2008 | 698 | 0.180 |
Why?
|
Social Support | 3 | 2019 | 2190 | 0.180 |
Why?
|
Sickness Impact Profile | 2 | 2012 | 297 | 0.180 |
Why?
|
Oximetry | 2 | 2021 | 458 | 0.170 |
Why?
|
Bone Density | 3 | 2021 | 3491 | 0.170 |
Why?
|
Milk, Human | 1 | 2025 | 490 | 0.170 |
Why?
|
Dyspnea | 1 | 2008 | 1351 | 0.170 |
Why?
|
Treatment Outcome | 14 | 2024 | 65194 | 0.160 |
Why?
|
Retrospective Studies | 17 | 2021 | 81537 | 0.160 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 475 | 0.160 |
Why?
|
Neonatal Screening | 1 | 2024 | 619 | 0.160 |
Why?
|
Insurance, Health | 3 | 2023 | 2520 | 0.160 |
Why?
|
Saline Solution, Hypertonic | 3 | 2024 | 116 | 0.160 |
Why?
|
Tibia | 2 | 2016 | 1064 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 364 | 0.160 |
Why?
|
Insurance Coverage | 2 | 2023 | 1945 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1088 | 0.160 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26282 | 0.150 |
Why?
|
Interdisciplinary Studies | 1 | 2019 | 85 | 0.150 |
Why?
|
Fees, Pharmaceutical | 1 | 2018 | 66 | 0.150 |
Why?
|
Crohn Disease | 2 | 2021 | 2281 | 0.150 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 267 | 0.150 |
Why?
|
Organizational Innovation | 1 | 2021 | 540 | 0.150 |
Why?
|
Middle Aged | 24 | 2024 | 223016 | 0.150 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1673 | 0.150 |
Why?
|
Behavior Therapy | 1 | 2024 | 886 | 0.150 |
Why?
|
Hospitals, Pediatric | 3 | 2021 | 1850 | 0.150 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2021 | 497 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2015 | 1319 | 0.150 |
Why?
|
Unemployment | 1 | 2019 | 211 | 0.150 |
Why?
|
Enteral Nutrition | 1 | 2024 | 802 | 0.140 |
Why?
|
Medication Adherence | 3 | 2024 | 2190 | 0.140 |
Why?
|
Body Image | 1 | 2022 | 645 | 0.140 |
Why?
|
Decision Making | 2 | 2024 | 3955 | 0.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1225 | 0.140 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2108 | 0.140 |
Why?
|
Chlorides | 2 | 2021 | 666 | 0.140 |
Why?
|
Nutritional Status | 2 | 2015 | 1620 | 0.140 |
Why?
|
Anxiety | 4 | 2021 | 4669 | 0.140 |
Why?
|
Drug Administration Schedule | 3 | 2016 | 4851 | 0.140 |
Why?
|
Infant | 13 | 2025 | 36426 | 0.140 |
Why?
|
Health Surveys | 3 | 2019 | 4058 | 0.140 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2430 | 0.130 |
Why?
|
Cephalosporins | 1 | 2017 | 200 | 0.130 |
Why?
|
Ibuprofen | 1 | 2018 | 228 | 0.130 |
Why?
|
Emigration and Immigration | 1 | 2019 | 405 | 0.130 |
Why?
|
Pancreas | 2 | 2024 | 1698 | 0.130 |
Why?
|
Efficiency | 1 | 2019 | 479 | 0.130 |
Why?
|
Sex Factors | 5 | 2021 | 10611 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 669 | 0.130 |
Why?
|
Pharmacies | 1 | 2018 | 171 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1657 | 0.130 |
Why?
|
Airway Resistance | 1 | 2017 | 407 | 0.130 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1188 | 0.130 |
Why?
|
Logistic Models | 4 | 2015 | 13273 | 0.120 |
Why?
|
Communication | 3 | 2018 | 3908 | 0.120 |
Why?
|
Prescriptions | 1 | 2018 | 388 | 0.120 |
Why?
|
Health Services Misuse | 1 | 2017 | 245 | 0.120 |
Why?
|
Health Status Indicators | 1 | 2021 | 967 | 0.120 |
Why?
|
Public Policy | 1 | 2019 | 551 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1348 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 779 | 0.120 |
Why?
|
Cohort Studies | 8 | 2021 | 41680 | 0.120 |
Why?
|
Eating | 1 | 2022 | 1539 | 0.120 |
Why?
|
Sampling Studies | 2 | 2014 | 610 | 0.120 |
Why?
|
Contraception | 1 | 2018 | 360 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 105 | 0.120 |
Why?
|
Knee Joint | 1 | 2023 | 1656 | 0.110 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 138 | 0.110 |
Why?
|
Terminal Care | 2 | 2017 | 1769 | 0.110 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6306 | 0.110 |
Why?
|
Mothers | 1 | 2025 | 2206 | 0.110 |
Why?
|
Directive Counseling | 1 | 2015 | 171 | 0.110 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39228 | 0.110 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 463 | 0.110 |
Why?
|
Fertility | 1 | 2018 | 770 | 0.110 |
Why?
|
Adolescent Medicine | 1 | 2014 | 72 | 0.110 |
Why?
|
Adolescent Health Services | 1 | 2015 | 217 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20133 | 0.110 |
Why?
|
Infant, Newborn | 4 | 2024 | 26380 | 0.110 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2414 | 0.110 |
Why?
|
Physician-Patient Relations | 3 | 2011 | 3270 | 0.100 |
Why?
|
Forecasting | 2 | 2014 | 2936 | 0.100 |
Why?
|
Databases, Factual | 2 | 2019 | 8060 | 0.100 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40097 | 0.100 |
Why?
|
Mechanical Phenomena | 2 | 2024 | 142 | 0.100 |
Why?
|
Airway Obstruction | 1 | 2017 | 672 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8037 | 0.100 |
Why?
|
Medically Uninsured | 1 | 2018 | 838 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1060 | 0.100 |
Why?
|
Body Composition | 1 | 2022 | 2441 | 0.100 |
Why?
|
Survivors | 2 | 2016 | 2373 | 0.100 |
Why?
|
Program Evaluation | 2 | 2018 | 2502 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5364 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 397 | 0.100 |
Why?
|
Otolaryngology | 1 | 2019 | 698 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12059 | 0.100 |
Why?
|
Genotype | 3 | 2021 | 13026 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3477 | 0.090 |
Why?
|
Propensity Score | 2 | 2018 | 1971 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5300 | 0.090 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 999 | 0.090 |
Why?
|
Aging | 3 | 2024 | 8725 | 0.090 |
Why?
|
Vocational Guidance | 1 | 2010 | 14 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 903 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1854 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1588 | 0.090 |
Why?
|
Palliative Care | 2 | 2017 | 3640 | 0.090 |
Why?
|
Nut Hypersensitivity | 1 | 2010 | 33 | 0.090 |
Why?
|
Egg Hypersensitivity | 1 | 2010 | 47 | 0.090 |
Why?
|
Depression | 3 | 2020 | 8223 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2555 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2022 | 3209 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 702 | 0.090 |
Why?
|
Ventilator Weaning | 1 | 2011 | 170 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 550 | 0.090 |
Why?
|
Patients | 2 | 2014 | 908 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2022 | 3314 | 0.080 |
Why?
|
Confidentiality | 1 | 2014 | 607 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 831 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 781 | 0.080 |
Why?
|
Professional Practice | 1 | 2011 | 314 | 0.080 |
Why?
|
Inhalation | 1 | 2010 | 142 | 0.080 |
Why?
|
Foundations | 2 | 2020 | 95 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5873 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1561 | 0.080 |
Why?
|
Boston | 4 | 2015 | 9334 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3444 | 0.080 |
Why?
|
Weight Gain | 1 | 2019 | 2356 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1912 | 0.080 |
Why?
|
Blood Glucose | 4 | 2024 | 6422 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.070 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 419 | 0.070 |
Why?
|
Respiratory Therapy | 1 | 2008 | 124 | 0.070 |
Why?
|
Ion Channel Gating | 2 | 2021 | 428 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2017 | 1311 | 0.070 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2011 | 329 | 0.070 |
Why?
|
Transportation | 1 | 2009 | 217 | 0.070 |
Why?
|
Absorptiometry, Photon | 3 | 2022 | 1707 | 0.070 |
Why?
|
Body Mass Index | 4 | 2022 | 13042 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2022 | 12417 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 109 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4248 | 0.070 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2007 | 91 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1447 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2022 | 22228 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3230 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1878 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1064 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1961 | 0.070 |
Why?
|
Exercise | 2 | 2022 | 5936 | 0.070 |
Why?
|
Family Relations | 1 | 2008 | 318 | 0.070 |
Why?
|
Vital Capacity | 2 | 2021 | 995 | 0.060 |
Why?
|
Bacteria | 1 | 2017 | 2210 | 0.060 |
Why?
|
Survival Analysis | 3 | 2018 | 10086 | 0.060 |
Why?
|
Massachusetts | 4 | 2014 | 8882 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10727 | 0.060 |
Why?
|
Self Efficacy | 1 | 2009 | 641 | 0.060 |
Why?
|
Aged | 11 | 2024 | 171163 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5889 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3272 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2020 | 0.060 |
Why?
|
Affective Symptoms | 1 | 2008 | 417 | 0.060 |
Why?
|
Prospective Studies | 7 | 2024 | 54807 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1006 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4627 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1208 | 0.060 |
Why?
|
Pregnancy Rate | 2 | 2017 | 654 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 834 | 0.060 |
Why?
|
Bionics | 1 | 2024 | 46 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2653 | 0.060 |
Why?
|
Medicaid | 1 | 2017 | 2833 | 0.050 |
Why?
|
Physicians | 4 | 2017 | 4591 | 0.050 |
Why?
|
Necrosis | 1 | 2008 | 1611 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15828 | 0.050 |
Why?
|
Risk Factors | 5 | 2018 | 74850 | 0.050 |
Why?
|
Biofeedback, Psychology | 1 | 2023 | 117 | 0.050 |
Why?
|
Data Collection | 2 | 2011 | 3318 | 0.050 |
Why?
|
Drug Monitoring | 2 | 2019 | 960 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2024 | 221 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2041 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1181 | 0.050 |
Why?
|
Knee | 1 | 2023 | 273 | 0.050 |
Why?
|
Cardiology | 1 | 2012 | 1696 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8721 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2022 | 147 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2021 | 124 | 0.040 |
Why?
|
Family | 2 | 2011 | 3208 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6321 | 0.040 |
Why?
|
Schools | 1 | 2009 | 1496 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2726 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6202 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3458 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6204 | 0.040 |
Why?
|
Electromyography | 1 | 2024 | 1398 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16714 | 0.040 |
Why?
|
Posture | 1 | 2023 | 955 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 152 | 0.040 |
Why?
|
Quinolines | 1 | 2024 | 769 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24275 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1142 | 0.040 |
Why?
|
Otitis Media | 1 | 2021 | 287 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 387 | 0.040 |
Why?
|
Israel | 1 | 2021 | 729 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4736 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 565 | 0.040 |
Why?
|
Transaminases | 1 | 2019 | 199 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1119 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1872 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12529 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4855 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12235 | 0.040 |
Why?
|
Diet Surveys | 1 | 2022 | 1159 | 0.040 |
Why?
|
Vomiting | 1 | 2021 | 646 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 292 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 527 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6870 | 0.040 |
Why?
|
Germany | 1 | 2019 | 882 | 0.040 |
Why?
|
North America | 1 | 2021 | 1287 | 0.030 |
Why?
|
Australia | 1 | 2021 | 1260 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2017 | 76 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5531 | 0.030 |
Why?
|
Health Care Costs | 1 | 2010 | 3241 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2019 | 578 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1253 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20690 | 0.030 |
Why?
|
Movement | 1 | 2023 | 1460 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 645 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1740 | 0.030 |
Why?
|
Breast Feeding | 1 | 2025 | 1363 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1818 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 4712 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 353 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 253 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1219 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 401 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 13082 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1752 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12822 | 0.030 |
Why?
|
New England | 1 | 2017 | 1059 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7842 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3430 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 991 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 301 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15401 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 329 | 0.030 |
Why?
|
Hemoptysis | 1 | 2014 | 151 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2894 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6891 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1607 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 30230 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1997 | 1865 | 0.030 |
Why?
|
Sputum | 1 | 2014 | 513 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 3061 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1729 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2589 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2864 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1997 | 1415 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3106 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1970 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3272 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7871 | 0.020 |
Why?
|
Esophageal pH Monitoring | 1 | 2011 | 203 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3343 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2194 | 0.020 |
Why?
|
Vital Signs | 1 | 2011 | 144 | 0.020 |
Why?
|
Prognosis | 3 | 2019 | 29890 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1812 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10575 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14643 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6603 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3612 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1422 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2206 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2012 | 3615 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6503 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1479 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 391 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2611 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4016 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1465 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2476 | 0.020 |
Why?
|
Vitamins | 1 | 2015 | 1631 | 0.020 |
Why?
|
Proton Pump Inhibitors | 1 | 2011 | 551 | 0.020 |
Why?
|
Community Health Centers | 1 | 2010 | 469 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3886 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2530 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8724 | 0.010 |
Why?
|
Poverty | 1 | 2015 | 2714 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2710 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1241 | 0.010 |
Why?
|
Cytokines | 1 | 1997 | 7417 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9656 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3851 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4555 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5449 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3784 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2515 | 0.010 |
Why?
|
Premature Birth | 1 | 2011 | 1830 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2027 | 0.010 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1997 | 15 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1997 | 40 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2701 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10843 | 0.010 |
Why?
|
Clone Cells | 1 | 1997 | 1670 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12973 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15540 | 0.000 |
Why?
|